Bridge between Triefenstein and Lengfurt: Truck closure from Monday!

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

From November 10, 2025, the bridge between Triefenstein and Lengfurt on MSP 36 will be closed to trucks over 7.5 tons due to damage discovered. The district office points out road safety measures.

Ab dem 10. November 2025 wird die Brücke zwischen Triefenstein und Lengfurt auf der MSP 36 für Lkw über 7,5 Tonnen gesperrt, aufgrund von festgestellten Schäden. Das Landratsamt weist auf Verkehrssicherheitsmaßnahmen hin.
From November 10, 2025, the bridge between Triefenstein and Lengfurt on MSP 36 will be closed to trucks over 7.5 tons due to damage discovered. The district office points out road safety measures.

Bridge between Triefenstein and Lengfurt: Truck closure from Monday!

In the coming days, road users in the region will have to adjust: From Monday, November 10, 2025, the bridge between Triefenstein and Lengfurt on MSP 36 (Neuffstrasse) will be closed to trucks with a permissible total weight of over 7.5 tons. The reason for this measure is damage that was discovered during recent investigations. The Main-Spessart District Office ordered this decision to ensure road safety.

Notices and signs will be installed in a timely manner to alert truck traffic to the closure. Cars and vehicles up to 7.5 tons are not affected by the measure, so that most drivers will continue to have a smooth flow of traffic. The local companies as well as the municipality of Triefenstein and local public transport have already been informed in order to minimize possible restrictions as best as possible.

Please understand

The district office appeals to all road users to show understanding for these necessary measures. User safety is the top priority. In the next few days we ask you to pay close attention to the signs and traffic information in order to avoid detours and reach your destination safely.

These measures represent an important step towards road safety in the region. We always keep readers up to date on further developments and relevant information on the topic.
For more information on the topic, visit the official notice on the website Main-Spessart press releases.

As an additional note, both health care and education are also important in other topics. For example, medications such as AUSTEDO XR® (deutetrabenazine) are used to treat chorea in Huntington's disease, although caution is advised here too. The risks that can arise from taking such medications should not be underestimated. The information page of AUSTEDO gives valuable information about the side effects and the necessary precautionary measures.